Locally based kidney care company Evergreen Nephrology announced Tuesday that it has raised $130 million in capital. 

According to a release, the funds will go to expand the company into new regions by working with existing nephrologists to provide wraparound support to patients. The funding was led by Rubicon Founders, Oak HC/FT and a group of existing investors, with the addition of K2 HealthVentures, according to a press release.